Naveris Inc.

About Naveris Inc.

Naveris is a molecular diagnostics company focused on oncology. It develops and commercializes blood-based tests that detect tumor-specific DNA alterations to monitor minimal residual disease and recurrence in patients with solid tumors. The company’s flagship product, NavDx, is a next-generation sequencing assay that identifies and tracks circulating tumor DNA in the plasma of individuals with HPV-driven head and neck cancers. By providing clinicians with real-time genomic insights, Naveris aims to improve treatment decisions, reduce overtreatment, and enhance long-term outcomes for cancer patients. The company operates a CLIA-certified laboratory and collaborates with academic medical centers nationwide.